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hnRNPU/TrkB Defines a Chromatin 
Accessibility Checkpoint for Liver 
Injury and Nonalcoholic Steatohepatitis 
Pathogenesis
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BaCKgRoUND aND aIMS: Nonalcoholic steatohepatitis 
(NASH) is a progressive liver disease that is characterized by 
liver injury, inflammation, and fibrosis. NASH pathogenesis 
is linked to reprogramming of chromatin landscape in the 
liver that predisposes hepatocytes to stress-induced tissue in-
jury. However, the molecular nature of the putative checkpoint 
that maintains chromatin architecture and preserves hepatocyte 
health remains elusive.
appRoaCH aND ReSUltS: Here we show that het-
erogeneous nuclear ribonucleoprotein U (hnRNPU), a nu-
clear matrix protein that governs chromatin architecture and 
gene transcription, is a critical factor that couples chromatin 
disruption to NASH pathogenesis. RNA-seq and chromatin 
immunoprecipitation-seq studies revealed an extensive over-
lap between hnRNPU occupancy and altered gene expression 
during NASH. Hepatocyte-specific inactivation of hnRNPU 
disrupted liver chromatin accessibility, activated molecular sig-
nature of NASH, and sensitized mice to diet-induced NASH 
pathogenesis. Mechanistically, hnRNPU deficiency stimulated 
the expression of a truncated isoform of TrkB (TRKB-T1) 
that promotes inflammatory signaling in hepatocytes and 
stress-induced cell death. Brain-derived neurotrophic factor 
treatment reduced membrane TRKB-T1 protein and protected 
mice from diet-induced NASH.
CoNClUSIoNS: These findings illustrate a mechanism 
through which disruptions of chromatin architecture drive the 
emergence of disease-specific signaling patterns that promote 
liver injury and exacerbate NASH pathogenesis. (Hepatology 
2020;71:1228-1246).
The epidemic of metabolic syndrome has greatly increased the risk for type 2 diabetes, cardio-vascular disease, and nonalcoholic fatty liver 
disease (NAFLD). NAFLD is characterized by chronic 
accumulation of excess fat in the liver and represents 
the most common metabolic liver disease linked to 
obesity and insulin resistance.(1-5) NAFLD encom-
passes a spectrum of liver pathologies ranging from 
relatively benign hepatic steatosis to nonalcoholic ste-
atohepatitis (NASH), first described by Ludwig et al. 
in 1980.(6) The latter is a more severe form of fatty liver 
disease that is associated with progressive liver injury, 
tissue inflammation, and liver fibrosis. NASH patho-
genesis is caused by multifactorial mechanisms that 
lead to pathological hepatic fat accumulation, stress- 
induced hepatocyte cell death, and persistently elevated 
inflammatory and tissue repair response.(2,3) Genetic 
polymorphisms of several loci have been demonstrated 
to contribute to NAFLD risk in humans,(1,5,7) under-
scoring the dysregulations of gene expression and/or 
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function as an important pathogenic factor in the ini-
tiation and progression of NASH.
The chromatin in eukaryotic cells stores genome 
information in a highly organized three-dimensional 
structure. Dynamic regulation of chromatin structure 
and accessibility is a fundamental aspect of transcrip-
tional control in response to external signals.(8,9) In addi-
tion, chromatin-remodeling complexes and histone- and 
DNA-modifying enzymes act in concert with transcrip-
tion factors to fine-tune gene expression.(10-12) Hepatic 
gene expression is exquisitely responsive to nutritional 
and hormonal signals and undergoes reprogramming in 
disease states such as NAFLD. Recent transcriptomic 
and proteomic studies have delineated a core molecular 
signature of diet-induced NASH in mice(13,14) and in 
human NASH livers.(15,16) Several features of NASH-
associated alterations of hepatic gene expression appear 
to be conserved during human NASH pathogenesis, 
including aberrant regulation of metabolic genes and 
induction of genes involved in immunity, inflamma-
tory response, and fibrosis. The latter reflects a coordi-
nated transcriptional response among multiple liver cell 
types during NASH development.(2,17) Despite this, 
the molecular nature of the nuclear factors that gov-
ern hepatocyte chromatin accessibility in liver disease 
remains elusive. Here we show that hnRNPU, a nuclear 
matrix protein, serves an indispensable role in the con-
trol of hepatic chromatin accessibility and gene expres-
sion. Hepatocyte-specific inactivation of hnRNPU 
exacerbates diet-induced NASH pathogenesis in mice, 
in part, through the aberrant induction of a truncated 
TrkB isoform that promotes inflammatory signaling in 
hepatocytes and stress-induced cell death.
Materials and Methods
aNIMal aND HUMaN StUDIeS
All animal studies were performed following the 
guideline established by the University Committee on 
Use and Care of Animals at the University of Michigan. 
Mice containing floxed hnRNPU were generated as 
described.(18) The Alb-Cre transgenic mice were pur-
chased from the Jackson Laboratory. For chow feeding, 
mice were fed Teklad 5001 laboratory diet. High-fat 
diet (HFD) contains 60% kcal% fat (D12492). The 
Amylin NASH (AMLN; D09100301) diet con-
tains 40% kcal% fat (18% of which was trans fat), 
22% fructose, and 2% cholesterol. Choline-deficient, 
L-amino acid-defined HFD (40% kcal%) contain-
ing 0.1% methionine (CDAHFD; A06071309) was 
used as an alternative NASH-inducing diet. All three 
special diets were purchased from Research Diets 
Inc. Human liver samples were obtained from the 
Liver Tissue Cell Distribution System at University 
of Minnesota and have been described.(19) Informed 
consent in writing was obtained from each patient and 
the study protocol conformed to the ethical guidelines 
of the 1975 Declaration of Helsinki as reflected in a 
priori approval by the appropriate institutional review 
committee.
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pRIMaRy HepatoCyteS StUDIeS
Primary hepatocytes were isolated using collagenase 
digestion from wild-type C57BL/6J mice, hnRNPU 
control (Ctrl), or liver-specific hnRNPU knockout 
(LKO) mice.(20) Adenoviral infection was performed 
on the same day of isolation. After 6 hours, transduced 
hepatocytes were switched to serum-free Dulbecco’s 
modified Eagle’s medium (DMEM) and cultured 
overnight before treatments. Tumor necrosis factor α 
(TNF-α; 20 ng/mL) was added 2 hours after the treat-
ment of palmitic acid (PA; 200 μM or 400 μM).
qpCR aND IMMUNoBlottINg 
aNalySIS
Real-time quantitative PCR (qPCR) was per-
formed as described,(21) using primers listed in 
Supporting Table S1. Immunoblotting was performed 
as described,(19) using antibodies listed in Supporting 
Table S2. For immunoprecipitation, liver nuclei were 
isolated from frozen liver tissues from mice fed chow 
or NASH diet as described.(22) Nuclear extracts were 
incubated with control immunoglobulin G or anti-
body specific for hnRNPU in the presence of protein 
G beads. Proteins associated with beads were ana-
lyzed by immunoblotting using antibodies specific for 
acetyllysine or phosphoserine/threonine.
ISolatIoN oF MeMBRaNe 
tRKB-t1
Hepa 1-6 mouse hepatoma cells (American Type 
Culture Collection, CRL-1830) were used to establish 
cell lines stably expressing TrkB-T1. Cells were trans-
duced with Murine Stem Cell Virus retroviral vector or 
a recombinant vector expressing TrkB-T1 followed by 
selection in the presence of puromycin (5 μg/mL) for 
at least 2 weeks. Stably transduced cells were switched 
to serum-free DMEM for 12  hours before treat-
ment with brain-derived neurotrophic factor (BDNF; 
248-BD, R&D) for 3 hours. Cell membrane fraction 
was extracted by ultracentrifugation, as described.(23)
plaSMa eNZyMeS aND lIVeR 
tag aNalySeS
Plasma alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) concentrations were measured 
using kits from Stanbio. Total liver triacylglycerol (TAG) 




Formalin-fixed, paraffin-embedded mouse 
liver sections were stained with hematoxylin and 
eosin (H&E) to evaluate steatosis and inflamma-
tory cells infiltration. Liver fibrosis was assessed 
by Picrosirius (Sirius) red (Polysciences, #24901) 
staining. For immunofluorescence microscopy, liver 
tissues were fixed with 10% formalin for 3  hours, 
30% sucrose in phosphate-buffered saline (PBS) 
overnight, embedded into an optimal cutting tem-
perature compound. Cryosections were permeabi-
lized in 0.1% Triton X-100 in PBS for 30 minutes, 
blocked with 10% horse serum for 1  hour, labeled 
with antibodies against mouse Decorin (DCN; 
R&D AF1060), F4/80 (Bio-Rad MCA497G), CD4 
(Thermo Fisher 14-0042-82), or CD8a (Thermo 
Fisher 14-0808-82) overnight, followed by incuba-
tion with a fluorophore-conjugated secondary anti-
body ( Jackson Immuno Research) for 1  hour. The 
stained sections were mounted with 4´,6-diamidi-
no-2-phenylindole-containing mounting medium 
(VECTASHIELD) and then viewed on a Nikon 
A-1-A fluorescence microscope.
lIVeR ataC SeQUeNCINg
Nuclei from frozen liver tissue were isolated as 
described.(24) A total of 50,000 isolated nuclei in 
each sample (Ctrl n  =  6; LKO n  =  6) were used in 
transposase reaction (Illumina). The libraries were 
sequenced on NovaSeq-6000 instrument with 50-bp 
paired-end reads after 2-step PCR amplification.(25)  
Assay for Transposase-Accessible Chromatin using 
sequencing (ATAC-seq) analysis pipeline was 
adapted from previous study.(26) The down-regulated 
(692) and up-regulated (2,045) peaks in LKO mice 
were independently used for motif-enrichment anal-
ysis (HOMER, findMotifs.pl). The University of 
California, Santa Cruz (UCSC) genome browser was 
used to visualize the ATAC-seq coverage. Both raw 
and processed data have been deposited into Gene 
Expression Omnibus database (GSE131336).
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RNa-seq Data aNalySIS
Liver RNA sequencing was performed on BGI 
500 instrument after polyA-selected mRNA isolation 
from HFD-fed control and hnRNPU LKO mice. 
The fastq files were aligned to the mouse reference 
genome (mm10) using the aligner STAR. All RNA-
seq raw data and processed data have been deposited 
into the GEO database (GSE131336). Gene enrich-
ment analysis was performed using MetaScape (www.
metas cape.org).
StatIStICal aNalySIS
All results are presented as mean ± SEM. Student 
t test was used to analyze the differences between 
two groups. Two-way analysis of variance (ANOVA) 
with multiple comparisons was used for statisti-
cal analysis of gene expression with the treatment 
of vehicle or PA plus TNF-α. A P value of less 
than 0.05 was considered statistically significant. 
Statistical methods and corresponding P values are 
indicated in figure legends.
Results
lIVeR-SpeCIFIC INaCtIVatIoN 
oF hnRNpU eXaCeRBateS  
DIet-INDUCeD NaSH 
patHogeNeSIS
hnRNPU is a nuclear matrix protein that main-
tains three-dimensional genome architecture in 
hepatocytes through its association with chroma-
tin.(27,28) These molecular observations led us to 
postulate that hnRNPU may serve as a chromatin 
checkpoint for liver metabolism and disease. In 
support of this, we found that over 20% of hepatic 
genes exhibiting hnRNPU occupancy were either 
up-regulated (508) or down-regulated (668) by 
more than 1.5-fold following AMLN diet–induced 
NASH (Fig. 1A; GSE75335 and GSE119340). 
Whereas hnRNPU mRNA and protein expres-
sion in the liver remained similar in healthy and 
NASH livers, serine/threonine phosphorylation 
of hnRNPU was increased following diet-induced 
NASH (Supporting Fig. S1). These findings suggest 
that posttranslational modifications of hnRNPU 
may play a role in modulating its function during 
NASH pathogenesis. The extensive overlap between 
hnRNPU chromatin association and transcriptomic 
reprograming in the liver prompted us to gener-
ate liver-specific hnRNPU knockout mice (LKO) 
and determine how chromatin structure governed 
by hnRNPU contributes to NASH pathogenesis. 
Compared with hnRNPUflox/flox control (Ctrl), mice 
with hepatocyte-specific inactivation of hnRNPU 
(Alb-Cre; hnRNPUflox/flox) were slightly smaller and 
exhibited normal blood glucose and plasma TAG 
levels and liver histology when fed standard rodent 
chow (Supporting Fig. S2A,B). Whereas plasma 
ALT was slightly elevated in LKO mice, hepatic 
expression of genes involved in glucose and lipid 
metabolism was largely unaffected by hnRNPU 
deficiency (Supporting Fig. S2C,D).
To probe the role of hnRNPU in the liver under 
metabolic stress conditions, we fed control and LKO 
mice CDAHFD to induce NASH pathogenesis. 
CDAHFD feeding has been shown to elicit the full 
spectrum of NASH pathologies, including hepatic 
steatosis, liver inflammation, and fibrosis.(29) Whereas 
hnRNPU LKO mice weighed slightly less than 
control, liver-to-weight ratio was higher than con-
trol group following 3  weeks of CDAHFD feeding 
(Supporting Fig. S3A) and appeared more rugged on 
the surface and rubbery on touch. Whereas liver TAG 
content and blood glucose levels remained compara-
ble, plasma ALT and AST concentrations were sig-
nificantly higher in LKO mice than control, indicating 
that hnRNPU inactivation in hepatocytes sensitized 
mice to CDAHFD-induced liver injury (Fig. 1B). 
Consistently, we observed more pronounced immune 
cell infiltration and liver fibrosis in LKO mice 
(Fig. 1C-F). Immunofluorescence staining indi-
cated that the abundance of F4/80+ macrophages 
and CD4+ and CD8+ T cells was markedly ele-
vated in LKO mouse livers (Fig. 1D,F; Supporting 
Fig. S3B,C). Deposition of pericellular collagen and 
accumulation of DCN, a proteoglycan secreted by 
hepatic stellate cells, was markedly enhanced by 
hnRNPU deficiency (Fig. 1C,E,F). Ductular reaction 
is a common feature of chronic liver injury in liver 
diseases including NASH.(30) Analysis of hepatic 
gene expression indicated that mRNA expression of 
genes associated with bile duct epithelial proliferation 
and ductular reaction (Spp1, Gli2, Afp, Prom1, Cd24a, 
and Ncam1) was significantly increased in hnRNPU 
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LKO mice following CDAHFD feeding (Supporting 
Fig. S4A,B). Consistently, we observed increased 
bile epithelial expansion and osteopontin immuno-
reactivity near the portal area in LKO mouse livers 
(Supporting Fig. S4C,D). These findings illustrate 
that hnRNPU inactivation elicits a full spectrum of 
NASH-associated liver pathologies.
Chronic HFD feeding promotes obesity, insulin 
resistance, and hepatic steatosis but fails to induce 
liver fibrosis in mice. In a separate set of studies, we 
examined whether hnRNPU deficiency sensitized 
mice to develop NASH pathologies on HFD feeding. 
Following 6 months of HFD feeding, hnRNPU LKO 
mice gained approximately 15% less body weight and 
exhibited lower liver-to-body weight ratio than con-
trol (data not shown). Histological analysis and liver 
TAG measurements indicated that although LKO 
mice exhibited slightly less severe hepatic steatosis, 
they had increased immune cell infiltration in the liver 
and developed more severe liver fibrosis as revealed 
by Sirius red staining (Fig. 2A,B). As such, pericel-
lular collagen accumulation was readily detectable in 
hnRNPU-deficient mouse livers but remained largely 
absent in control mice. As liver fibrosis is a hallmark 
of NASH pathogenesis, these findings strongly sug-
gest that hepatic hnRNPU functions to restrict the 
progression from steatosis to NASH.
RepRogRaMMINg oF tHe lIVeR 
tRaNSCRIptoMe IN ReSpoNSe 
to hnRNpU INaCtIVatIoN
To delineate the effects of hnRNPU deficiency on 
liver transcriptome, we performed RNA-seq analysis 
on total liver RNA from HFD-fed control and LKO 
mice. Our analysis identified a total of 483 genes that 
were differentially regulated by hnRNPU inactivation 
(False Discovery Rate (FDR)  <  0.1). Gene ontology 
analysis indicated that down-regulated genes (202) 
were enriched for monocarboxylic acid and lipid 
metabolism, whereas up-regulated genes (281) were 
primarily responsible for host defense, innate immune 
response, and inflammation (Fig. 2C). Our recent 
RNA-seq studies comparing healthy and NASH livers 
defined a molecular signature of diet-induced NASH 
in mice.(14) Remarkably, 89 of 281 genes elevated in 
hnRNPU LKO livers were also induced in NASH 
mouse livers (Fig. 2D). qPCR analysis confirmed 
the induction of genes involved in type I interferon 
response (Ifit1, Ifit3, Ifi27l2a, Ifih1) and macrophage 
function (C1qc, Cd5l, Gpnmb, Trem2) in LKO livers 
(Fig. 2E). These results indicate that hnRNPU defi-
ciency elicits transcriptional reprogramming in the 
liver that is characteristic of NASH pathogenesis.
We recently performed single-cell RNA-seq 
(scRNA-seq) analysis of liver cells in healthy and 
diet-induced NASH mice.(31) This scRNA-seq data 
set contains gene expression data for hepatocytes and 
nonparenchymal cells at the single-cell resolution. To 
delineate the cellular origins of hnRNPU-regulated 
genes in the liver, we obtained expression values for 
these genes among different liver cell types from the 
scRNA-seq data set. Clustering analysis revealed that 
a large proportion of the up-regulated and down- 
regulated genes were enriched in hepatocytes 
(Supporting Fig. S5A), supporting the notion that 
hnRNPU deficiency likely directly perturbed hepato-
cyte gene expression. Several cell types involved in 
immune response, including macrophage, T cell, B cell, 
and dendritic cell, were enriched for genes that were up- 
regulated in hnRNPU LKO livers (Supporting 
Fig. S5B). These integrated data analyses illustrate a 
coordinated transcriptomic response among diverse liver 
cell types as a result of hepatocyte-specific hnRNPU 
inactivation.
hnRNpU goVeRNS lIVeR 
CHRoMatIN aCCeSSIBIlIty
We next determined how hnRNPU inactivation 
alters liver chromatin accessibility and transcriptome 
during NASH pathogenesis. We performed ATAC-
seq on liver nuclei isolated from six pairs of HFD-
fed control and LKO mice to delineate the role of 
FIg. 1. Hepatocyte-specific inactivation of hnRNPU exacerbates CDAHFD-induced NASH. (A) Pie chart depicting NASH regulation 
of the liver genes containing binding sites for hnRNPU. (B) Plasma ALT and AST levels. (C) H&E and Sirius red staining of liver sections 
from mice fed CDAHFD for 3 weeks. Arrowheads indicate infiltrated immune cells. Scale bars: 200 μm. (D) F4/80 immunofluorescence 
staining of liver sections. Scale bars: 100 μm. (E) DCN immunofluorescence staining of liver sections. Scale bars: 100 μm. (F) Quantification 
of immune cell infiltration, collagen deposition, and DCN- and F4/80-positive areas. Data in (B) and (F) represent mean ± SEM (Ctrl 
n = 8; LKO n = 6). **P < 0.01, Ctrl versus LKO, two-tailed unpaired Student t test. Abbreviation: DAPI, 4´,6-diamidino-2-phenylindole.
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hnRNPU in governing liver chromatin accessibility.(25) 
We identified a total of 159,578 transposase-accessi-
ble chromatin peaks, 2,045 and 692 of which showed 
decreased and increased accessibility (FDR  <  0.1), 
respectively, as a result of hnRNPU inactivation 
(Fig. 3A). Using more stringent criteria, we revealed 
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a list of ATAC-seq peaks exhibiting differential regu-
lation by over 2-fold in LKO livers with FDR < 0.05 
(Fig. 3B). As such, multiple ATAC peaks within the 
Cyp4a10 locus were significantly lower in hnRNPU 
LKO livers (Fig. 3C). On the contrary, chroma-
tin accessibility for Ntrk2, which encodes the TrkB 
receptor tyrosine kinase, was enhanced by hnRNPU 
deficiency. We next performed transcription factor 
motif-enrichment analysis on ATAC-seq peaks that 
were differentially regulated by hnRNPU inactiva-
tion. We observed that binding sites predicted for 
several transcription factors, including ETS, GATA4, 
SOX9, ERRA, and ZNF711, were highly enriched at 
genomic locations exhibiting reduced accessibility in 
hnRNPU LKO mouse livers (Fig. 3D). In contrast, 
the top five motifs enriched for up-regulated chro-
matin peaks corresponded to predicted binding sites 
for HNF1B, RARA, THRB, SOX18, and FOXC1. 
These results illustrate a global effect of hnRNPU 
inactivation on liver chromatin accessibility in both 
directions.
hnRNpU DeFICIeNCy eNHaNCeS 
INFlaMMatoRy SIgNalINg aND 
HepatoCyte INJURy
As shown above, hnRNPU LKO mice developed 
more severe NASH pathologies following CDAHFD 
feeding. Accordingly, mRNA expression of genes 
involved in liver fibrosis (Col1a1, Tgfb1, Timp1) 
and inflammatory response (Trem2, Gpnmb, Ms4a7, 
H2-Ab1, Ccl2) was elevated in the LKO mouse livers 
(Supporting Fig. S6A,B). Immunoblotting analysis 
revealed that hnRNPU deficiency increased protein 
expression of TRAF2, a mediator of signaling by the 
TNF family receptors, and markedly increased pro-
tein levels of p52, a key effector of the noncanoni-
cal nuclear factor kappa B (NF-kB) pathway.(32) 
Other factors involved in inflammatory signaling, 
including RELB and phosphorylated p65, p38, and 
c-Jun N-terminal kinase ( JNK), and phosphorylated 
extracellular signal-regulated kinase (ERK) were also 
elevated in hnRNPU LKO mouse livers (Supporting 
Fig. S6C).
To determine whether hnRNPU regulates hepato-
cyte inflammatory signaling in a cell-autonomous 
manner, we performed studies using primary hepato-
cytes isolated from control and hnRNPU LKO mice. 
Consistent with in vivo results, protein levels of p52, 
phosphorylated p65, and TrkB-T1 were elevated in 
hnRNPU-deficient hepatocytes (Fig. 4A). Exposure 
of hepatocytes to a combination of PA and TNF-α 
has been used to mimic NASH-associated metabolic 
stress and inflammatory signaling.(19,33) hnRNPU defi-
ciency further increased p52 and p-JNK protein levels, 
as well as nuclear p65 level, in hepatocytes in response 
to acute treatments (15 minutes) with PA plus TNF-α 
(Fig. 4A,B). Following a more prolonged PA plus 
TNF-α treatment, hnRNPU-deficient hepatocytes 
showed increased sensitivity to stress-induced cell 
death, as indicated by elevated levels of cleaved poly(ad-
enosine diphosphate ribose) polymerase and Caspase 3, 
markers of apoptotic cell death (Fig. 4C). We previ-
ously demonstrated that FADD-like apoptosis regula-
tor plays an important role in protecting hepatocytes 
from stress-induced cell death.(19) Consistently, protein 
levels of FADD-like apoptosis regulator were dimin-
ished in the absence of hnRNPU (Fig. 4C). Induction 
of IL1b, Tnf, and Nos2 expression was also augmented 
in knockout hepatocytes (Fig. 4D). These results 
demonstrated that hnRNPU deficiency enhances 
inflammatory signaling in hepatocytes in response to 
metabolic stress and cytokines, thereby promoting liver 
injury and NASH progression.
trkB INDUCtIoN IN NaSH lIVeR 
pReDISpoSeS HepatoCyteS to 
StReSS-INDUCeD INJURy
The above ATAC-seq and RNA-seq studies 
revealed a crucial role of hnRNPU in governing liver 
chromatin architecture and transcriptome. Notably, 
FIg. 2. hnRNPU deficiency worsens NASH pathologies in mice following HFD feeding. (A) H&E and Sirius red staining of liver 
sections. Arrowheads indicate infiltrated immune cells. Scale bars: 200  μm. (B) Quantification of liver TAG content, immune cell 
infiltration, and collagen deposition. (C) Heat map of hepatic genes up-regulated or down-regulated in hnRNPU LKO mice (left). 
Enrichment of biological processes in these two clusters is indicated (right). (D) A cluster of hepatic genes up-regulated in HFD-fed LKO 
mice (heat map, left) and following AMLN diet–induced NASH (bar graph, right). Liver RNA-seq data from mice fed chow or AMLN 
diet were used for the bar graph. (E) qPCR analysis of hepatic gene expression in HFD-fed mice (Ctrl n = 6; LKO n = 10). Data in (B) 
and (C) represent mean ± SEM. *P < 0.05, **P < 0.01; Ctrl versus LKO, two-tailed unpaired Student t test.
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FIg. 3. ATAC-seq analysis of liver chromatin accessibility. ATAC-seq was performed on liver nuclei isolated from Ctrl (n = 6) and LKO 
(n = 6) mice after 6 months of HFD feeding. (A) Pie chart showing ATAC-seq peaks altered by hnRNPU deficiency. (B) Heat map 
representation of peaks increased or decreased by over 2-fold in hnRNPU LKO mouse livers. (C) UCSC genome browser tracks near 
Ntrk2 and Cyp4a10. (D) Motif-enrichment analysis of the up-regulated and down-regulated ATAC-seq peaks.
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hnRNPU deficiency increased chromatin accessibility 
at the Ntrk2 locus and its mRNA expression (Figs. 2E, 
3B,C). Two predominant isoforms of TrkB correspond 
to the full-length isoform (FL-TrkB) and a truncated 
isoform (TrkB-T1) that lacks most of the intracellular 
domains.(34,35) The TrkB-T1 transcript originates from 
the use of an alternative 3′ exon, resulting in premature 
termination of transcription and production of a trun-
cated protein. Inspection of liver RNA-seq tracks from 
mice fed chow or AMLN diet revealed that NASH 
increased the expression of TrkB in an isoform-specific 
manner (Fig. 5A). qPCR analysis using isoform-specific 
primers indicated that TrkB-T1, but not FL-TrkB, 
was markedly increased during AMLN diet–induced 
NASH (Fig. 5B). Consistent with these qPCR results, 
we observed strong induction of TRKB-T1 protein 
expression in NASH liver lysates following 3 and 
6 months of AMLN diet feeding (Fig. 5C). The induc-
tion of TrkB-T1 expression was associated with ele-
vated P52 levels and increased phosphorylation of P65 
and JNK, molecular markers of inflammatory cytokine 
signaling during NASH pathogenesis.
We next examined whether hepatic TrkB-T1 
mRNA expression is associated with severity of 
FIg. 4. Cell-autonomous regulation of hepatocyte signaling and gene expression by hnRNPU. The following experiments were performed 
in primary hepatocytes prepared from Ctrl or LKO mice. Hepatocytes were cultured in serum-free media overnight before treatments. 
PA (200 μM) was added 2 hours before to the addition of TNF-α (20 ng/mL). (A) Immunoblots of total lysates from hepatocytes 
treated with vehicle (-) or PA + TNF-α (+) for 15 minutes. (B) Immunoblots of cytosolic or nuclear extracts from treated hepatocytes. 
(C) Immunoblots of total lysates from hepatocytes treated with vehicle (-) or PA + TNF-α (+) for 24 hours. (D) qPCR analysis of gene 
expression from hepatocytes treated with vehicle or PA + TNF-α (+) for 6 hours (n = 3). Data represent mean ± SEM. **P < 0.01, Ctrl 
versus LKO in vehicle-treated cells. #P < 0.05, ##P < 0.01, Ctrl versus LKO in hepatocytes treated with PA + TNF-α. Two-way ANOVA 
with multiple comparisons. Abbreviation: Veh, vehicle.
Hepatology, april 2020XIONG ET AL.
1238
Hepatology, Vol. 71, No. 4, 2020 XIONG ET AL.
1239
liver injury in NASH. In a cohort of wild-type mice 
fed AMLN diet exhibiting different degree of liver 
injury, we observed that hepatic TrkB-T1 expression 
strongly correlated with plasma ALT and AST lev-
els (Fig. 5D). Using immunofluorescence staining, 
we confirmed that TrkB induction was restricted to 
hepatocytes, which were marked by nuclear staining 
of hepatocyte nuclear factor 4α, a hepatocyte-specific 
transcription factor (Fig. 5E). Importantly, increased 
TrkB-T1 mRNA and protein expression was observed 
in human NASH liver biopsies (Fig. 6A,B). Similar 
to diet-induced NASH in mice, increased TrkB-T1 
expression was associated with induction of JNK 
and P65 phosphorylation and increased P52 protein 
expression, suggesting that both the canonical and 
noncanonical NF-kB pathway is enhanced during 
human NASH pathogenesis. Interestingly, protein 
levels of RIPK3 and phosphorylated MLKL, two 
markers of necroptotic cell death, and cleaved Caspase 
3 were increased in human NASH livers (Fig. 6B). 
We performed qPCR and immunoblotting analyses 
on control and hnRNPU LKO mouse livers using iso-
form-specific primers and confirmed that hnRNPU 
inactivation significantly increased hepatic expression 
of TrkB-T1 under both HFD and CDAHFD feeding 
conditions (Fig. 6C,D). The induction of TRKB-T1 
expression was also observed in hnRNPU-deficient 
hepatocytes, indicating that this is a cell-autonomous 
effect of hnRNPU (Fig. 4A). These results illustrate 
that TrkB-T1 induction is a common molecular fea-
ture of NASH pathogenesis in mice and humans. In 
addition, hnRNPU regulates the expression of TrkB 
in an isoform-specific manner.
The biological function of the truncated TrkB iso-
form in hepatocytes remains unexplored. TRKB-T1 
stimulation has been shown to trigger ERK phos-
phorylation and regulates actin dynamics in glia 
cells.(36-38) However, BDNF appeared to have modest 
effects on ERK phosphorylation and actin cytoskele-
tal organization in primary hepatocytes (Supporting 
Fig. S7). To investigate whether TrkB-T1 plays a 
protective or detrimental role in stress signaling, we 
transduced cultured primary hepatocytes with recom-
binant adenoviral vectors expressing green fluores-
cent protein (GFP) or TrkB-T1 and examined their 
response to PA/TNF-α treatments. At the baseline, we 
observed that adenoviral overexpression of TrkB-T1 
led to slightly elevated levels of P52 and phosphor-
ylated P65 and JNK in transduced hepatocytes. On 
PA/TNF-α treatments for 15 minutes, TrkB-T1 over-
expression augmented the stimulation of JNK and 
P65 phosphorylation (Fig. 6E), and nuclear transloca-
tion of P65 (Fig. 6F), suggesting that TrkB-T1 facil-
itates activation of signaling pathways in response to 
metabolic stress and cytokine stimulation. Compared 
with GFP control, the levels of cleaved Caspase 3 
were markedly higher in hepatocytes transduced with 
adenoviral TrkB-T1 following prolonged exposure to 
PA/TNF-α. Analysis of gene expression in treated 
hepatocytes indicated that TrkB-T1 overexpres-
sion augments the induction of Tnf, Il1b, Nos2, and 
Il6 expression under PA/TNF-α treated condition 
(Fig. 6G). These studies demonstrate that TrkB-T1 
overexpression is sufficient to enhance inflammatory 
signaling in hepatocytes in response to stress signals 
relevant for NASH pathogenesis.
BDNF ReDUCeS MeMBRaNe 
tRKB-t1 aND pRoteCtS MICe 
FRoM DIet-INDUCeD NaSH
TRKB-T1 contains an extracellular ligand-binding 
domain identical to FL-TRKB, yet it lacks the intra-
cellular receptor tyrosine kinase domain. As a result, 
TRKB-T1 is unable to trigger the canonical down-
stream signaling pathway in response to its ligand 
BDNF. Interestingly, we found that BDNF treat-
ment of mouse hepatoma cells stably overexpressing 
TRKB-T1 diminished membrane TRKB-T1 pro-
tein levels (Fig. 7A), whereas the levels of epidermal 
growth factor receptor remained largely unchanged 
by BDNF. Importantly, BDNF treatment decreased 
endogenous TRKB-T1 protein levels in primary 
hepatocytes isolated from hnRNPU LKO mice and 
FIg. 5. Induction of TrkB-T1 expression in mouse NASH. (A) UCSC genome browser view of Ntrk2 liver RNA-seq reads from mice 
fed chow or AMLN diet (n = 3). (B) qPCR analysis of TrkB isoforms in the liver from mice fed chow or AMLN diet (n = 3) using 
isoform-specific primers. Data represent mean ± SEM. *P < 0.05, **P < 0.01; AMLN versus chow, two-tailed unpaired Student t test. 
(C) Immunoblots of total liver lysates from chow or ALMN diet–fed mice. (D) Correlation of liver TrkB-T1 mRNA expression with 
plasma ALT and AST in a cohort of AMLN diet–fed wild-type mice exhibiting different severity of liver injury (n = 15). (E) Representative 
TrkB immunofluorescence in chow- and AMLN diet–fed mouse livers. Arrowheads indicate HNF4α-positive hepatocytes. Scale bars: 
100 μm. Abbreviations: DAPI, 4´,6-diamidino-2-phenylindole; HNF4α, hepatocyte nuclear factor 4α.
Hepatology, april 2020XIONG ET AL.
1240
ameliorated PA/TNF-α-induced Casp3 cleavage 
and hepatocyte cell death (Fig. 7B,C). These results 
suggest that BDNF may directly modulate stress- 
induced hepatocyte injury through its regulation of 
TRKB-T1 protein levels. Although the exact mech-
anisms through which BDNF reduces membrane 
TRKB-T1 remain unknown, a likely scenario is that 
ligand binding triggers endocytosis and subsequent 
Hepatology, Vol. 71, No. 4, 2020 XIONG ET AL.
1241
lysosomal degradation of TRKB-T1 in hepatocytes. 
In fact, BDNF has been reported to bind TRKB and 
promote its endocytosis and degradation.(39)
A prediction of the above findings is that BDNF 
overexpression may diminish TRKB-T1 protein levels 
in the liver, thereby alleviating diet-induced NASH 
pathogenesis. To test this, we generated a recombi-
nant adeno-associated virus (AAV) overexpressing 
BDNF under the control of liver-specific thyroid hor-
mone-binding globulin promoter. As expected, tail vein 
injection of AAV-BDNF resulted in robust BDNF 
mRNA and protein expression in the liver (Fig. 7D; 
Supporting Figs. S8D and S9A). BDNF overexpres-
sion had modest effects on plasma parameters, liver 
histology, and hepatic gene expression when mice 
were fed chow diet (Supporting Fig. S8). Following 
AMLN diet feeding, mice transduced with AAV-
BDNF exhibited significantly lower plasma ALT and 
AST levels and reduced P52 and RIPK3 protein levels 
and P65, P38, and JNK phosphorylation in the liver 
than control (Fig. 7E). mRNA expression of proin-
flammatory genes (Ccl4, Il10, Cd74, H2-Ab1i Gpnmb, 
and Trem2) and fibrosis markers (Col1a1 and Col1a2) 
was significantly decreased by BDNF overexpression 
(Fig. 7F). Although TrkB-T1 mRNA levels remained 
similar between two groups, its protein expression was 
notably lower in the AAV-BDNF group (Fig. 7D). 
Histological staining indicated that hepatic steatosis, 
liver fibrosis, and DCN accumulation were mark-
edly improved in mice transduced with AAV-BDNF 
(Fig. 8A,B). Liver inflammation, as indicated by the 
abundance of macrophages and T cells, was greatly 
attenuated in response to BDNF overexpression 
(Fig. 8C,D; Supporting Fig. S9B,C). Together, these 
results demonstrate that elevating BDNF levels is 
sufficient to reduce TRKB-T1 protein expression and 
ameliorate diet-induced NASH pathologies in mice.
Discussion
The liver transcriptome is highly respon-
sive to nutritional, hormonal, and circadian cues. 
Reprogramming of the liver transcriptome as a con-
sequence of altered epigenetic state and chromatin 
accessibility in hepatocytes is a fundamental feature 
of NAFLD.(14,40,41) Despite this, the molecular nature 
of the regulatory network that governs chromatin 
architecture in the liver remains obscure. In this study, 
we uncovered hnRNPU as a regulator of chroma-
tin accessibility across the genome that functions to 
protect hepatocytes from stress-induced cell injury 
(Fig. 8E). Hepatocyte-specific inactivation of hnRNPU 
exacerbated diet-induced NASH pathogenesis in 
mice, including liver injury, inflammation, and fibro-
sis. hnRNPU is a nuclear matrix protein that regulates 
three-dimensional chromatin structure and gene tran-
scription.(27,28) In the heart, hnRNPU is required for 
postnatal development and cardiac function.(18) The 
expression levels of hnRNPU in the liver remained 
largely unchanged during diet-induced NASH in 
mice and in human NASH, suggesting that other 
mechanisms are likely at work to regulate the dynamic 
chromatin response. In support of this, hnRNPU 
phosphorylation at serine/threonine residues appeared 
to be enhanced in diet-induced NASH. However, the 
exact residues, their upstream kinases, and the effects 
of hnRNPU phosphorylation on its biological func-
tions remain currently unknown. Previous studies have 
demonstrated that hnRNPU interacts with a number 
of nuclear proteins including heterochromatin protein 
1 alpha, the transcription factor Zbtb7b, and the long 
noncoding RNA Blnc1.(21,42,43) It is likely that regu-
lation of these hnRNPU-interacting factors may also 
underlie its effects on chromatin structure in response 
to physiological and pathophysiological stimuli.
FIg. 6. Regulation and functional role of TRKB-T1 in hepatocyte stress response. (A) qPCR analysis of TRKB-T1 expression in liver 
biopsies obtained from non-NASH control (n = 7) and patients with NASH (n = 7). Data represent mean ± SEM. *P < 0.05, NASH 
versus control, two-tailed unpaired Student t test. (B) Immunoblots of total liver lysates from non-NASH and NASH individuals. 
(C) qPCR analysis of liver TrkB-T1 expression in control and hnRNPU LKO mice fed HFD (Ctrl n = 6; LKO n = 10) or CDAHFD 
(Ctrl n = 8; LKO n = 6). Data represent mean ± SEM. **P < 0.01, LKO versus Ctrl, two-tailed unpaired Student t test. (D) Immunoblots 
of total liver lysates from mice fed HFD or CDAHFD. (E) Immunoblots of total cell lysates from primary hepatocytes transduced with 
GFP or TrkB-T1 adenovirus followed by treatment with vehicle (-) or PA + TNF-α (+) for 15 minutes (top) or 24 hours (bottom). 
(F) Immunoblots of cytosolic or nuclear extracts from transduced hepatocytes treated with vehicle (-) or PA + TNF-α (+) for 15 minutes. 
(G) qPCR analysis of gene expression in transduced hepatocytes treated with vehicle or PA + TNF-α for 6 hours (n = 3). Data represent 
mean ± SEM. #P < 0.05, ##P < 0.01, TrkB-T1 versus GFP in hepatocytes treated with PA + TNF-α. Two-way ANOVA with multiple 
comparisons. Abbreviation: Veh, vehicle.
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FIg. 7. BDNF decreases membrane TRKB-T1 and protects mice from diet-induced NASH. (A) Immunoblots of membrane proteins 
isolated from Hepa 1-6 cells stably expressing TrkB-T1. Transduced cells were treated with vehicle (-) or BDNF in the presence or absence 
of cycloheximide (4 μM). (B) Immunoblots of total cell lysates from primary hepatocytes isolated from hnRNPU LKO mice. Hepatocytes 
were pretreated with BDNF (100 ng/mL) for 2 hours before addition of PA (200 μM) and TNF-α (20 ng/mL). (C) Morphology of 
treated hepatocytes. Hepatocytes were pretreated with BDNF (100 ng/mL) for 2 hours before addition of PA (400 μM) and TNF-α 
(20 ng/mL). (D) Immunoblots of total liver lysates from mice transduced with AAV-GFP or AAV-BDNF (GFP n = 7; BDNF n = 6). 
(E) Metabolic parameters and plasma ALT/AST levels in transduced mice. (F) qPCR analysis of hepatic gene expression. Data in 
(E) and (F) represent mean ± SEM. *P < 0.05, **P < 0.01; BDNF versus GFP, two-tailed unpaired Student t test. Abbreviation: CHX, 
cycloheximide.
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FIg. 8. AAV-mediated BDNF overexpression protects mice from diet-induced NASH pathogenesis. (A) H&E and Sirius red staining 
of liver sections from mice transduced with AAV-GFP or AAV-BDNF. Arrowheads indicate infiltrated immune cells. Scale bars: 200 μm. 
(B) F4/80 immunofluorescence staining of liver sections. Scale bars: 100 μm. (C) DCN immunofluorescence staining of liver sections. 
Scale bars: 100 μm. (D) Quantification of immune cell infiltration, collagen deposition, and DCN and F4/80 positive areas. Data represent 
mean ± SEM (GFP n = 7; BDNF n = 6). *P < 0.05, **P < 0.01; GFP versus BDNF, two-tailed unpaired Student t test. (E) Model depicting 
the role of hnRNPU/TRKB-T1 as a chromatin accessibility checkpoint for NASH pathogenesis. Abbreviation: DAPI, 4´,6-diamidino-
2-phenylindole.
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Unlike transcriptional coactivators and repressors, 
the effects of hnRNPU inactivation on chromatin 
accessibility appeared to be bidirectional, suggesting 
that hnRNPU acts in a context-dependent manner to 
influence hepatic gene expression. Integration of the 
RNA-seq data from the hnRNPU LKO mouse liv-
ers with single-cell RNA-seq data revealed an inter-
esting feature of liver gene regulation by hnRNPU 
(Supporting Fig. S4A). Although many differentially 
expressed genes exhibit highest expression in hepato-
cytes, among different liver cell types, mRNA expres-
sion of a large number of genes altered by hnRNPU 
deficiency appeared to be enriched in nonparenchy-
mal cells. Remarkably, many genes up-regulated in 
hnRNPU LKO livers are restricted to cells involved 
in immunity and inflammation, including macro-
phage, T cell, B cell, and dendritic cell (Supporting 
Fig. S4B). These findings illustrate the prevalence of 
intercellular crosstalk between hepatocytes and other 
cell types in the liver. Although the exact mechanisms 
that mediate immune cell gene expression remain 
unknown, a likely scenario is that hnRNPU deficiency 
sensitizes hepatocytes to stress-induced injury, leading 
to enhanced inflammatory response and stellate cell 
activation.
The receptor tyrosine kinase TrkB is a high- 
affinity receptor for neurotrophins that is known to 
promote neuronal differentiation and survival.(44,45) 
A number of TrkB transcripts have been described 
as a result of alternative splicing. The full-length 
isoform contains the extracellular ligand-binding 
domain and intracellular tyrosine kinase domain, 
whereas TrkB-T1 is truncated immediately after 
the transmembrane domain and lacks the kinase 
domain.(46) Our RNA-seq study comparing healthy 
and NASH mouse livers revealed that TrkB-T1, 
but not the FL-TrkB isoform, was among the most 
highly induced genes in the liver following diet-in-
duced NASH (Fig. 5A). It is notable that TrkB 
expression is largely absent in healthy liver. As such, 
the induction of TrkB-T1 represents an emergent 
property of NASH hepatocytes that may be func-
tionally linked to NASH pathogenesis. This isoform- 
specific induction of TrkB expression was observed 
in human NASH liver biopsies, illustrating that 
dysregulation of TrkB expression is likely a con-
served feature of NASH (Fig. 6A,B). Interestingly, 
a recent study showed that expression of TrkB and 
its ligand BDNF was induced in the liver follow-
ing bile duct ligation(47); however, the exact iso-
form(s) involved was not determined. TrkB-T1 has 
been shown to regulate calcium signaling and actin 
dynamics(36-38) and may act as a dominant nega-
tive receptor for BDNF, thereby attenuating BDNF 
signaling through TrkB.(46) Our functional studies 
demonstrate that TRKB-T1 promotes stress-in-
duced hepatocyte death whereas its ligand BDNF 
diminishes membrane TRKB-T1 protein levels and 
protects mice from diet-induced NASH.
tRaNSlatIoNal aND ClINICal 
poteNtIal oF tHe StUDy
This work delineates a molecular pathway that 
links chromatin regulation to NASH pathogenesis. 
The aberrant induction of TRKB-T1 expression in 
mouse and human NASH is particularly intriguing. 
Our results support a deleterious effect of membrane 
TRKB-T1 on hepatocyte health, whereas BDNF-
mediated down-regulation elicits protective activi-
ties. As such, the BDNF/TRKB-T1 axis may present 
unique molecular targets for the therapeutic interven-
tion of NASH.
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